Greater Cannabis Company (GCAN) Operating Expenses (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Operating Expenses of $33376.0 in Q1 2026, down 37.97% quarter-over-quarter from $53806.0 in Q4 2025, and down 23.34% on a YoY basis from $43536.0 in Q1 2025.
Greater Cannabis Company (GCAN) Operating Expenses (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Operating Expenses history runs 10 years deep, the most recent figure standing at $33376.0 for Q1 2026.
- In Q1 2026, Operating Expenses fell 23.34% year-over-year to $33376.0; the TTM figure through Mar 2026 stood at $172845.0 (up 7.45% YoY), while the FY2025 annual figure was $183005.0, up 17.1% from the prior year.
- Operating Expenses was $33376.0 for Q1 2026 at Greater Cannabis Company, down from $53806.0 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $53806.0 in Q4 2025 to a low of $33376.0 in Q1 2026.
- Historically, Operating Expenses has averaged $42650.4 across 5 years, with a median of $42267.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses sank 64.81% in 2022, then surged 43.01% in 2025.
- A 5-year view of Operating Expenses shows it stood at $42267.0 in 2022, then increased by 4.16% to $44027.0 in 2023, then slipped by 14.54% to $37625.0 in 2024, then soared by 43.01% to $53806.0 in 2025, then sank by 37.97% to $33376.0 in 2026.
- The last three Operating Expenses figures came in at $33376.0 (Q1 2026), $53806.0 (Q4 2025), and $37412.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 96.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 475.11 Mn |
| 10 | Greater Cannabis Company | - | - | - | 33,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,376.00 |
| Dec 31, 2025 | 53,806.00 |
| Sep 30, 2025 | 37,412.00 |
| Jun 30, 2025 | 48,251.00 |
| Mar 31, 2025 | 43,536.00 |
| Dec 31, 2024 | 37,625.00 |
| Sep 30, 2024 | 40,443.00 |
| Jun 30, 2024 | 39,257.00 |
| Mar 31, 2024 | 38,951.00 |
| Dec 31, 2023 | 44,027.00 |
| Sep 30, 2023 | 50,465.00 |
| Jun 30, 2023 | 41,404.00 |
| Mar 31, 2023 | 39,468.00 |
| Dec 31, 2022 | 42,267.00 |
| Sep 30, 2022 | 49,304.00 |
| Jun 30, 2022 | 43,034.00 |
| Mar 31, 2022 | 42,430.00 |
| Dec 31, 2021 | 120,102.00 |
| Sep 30, 2021 | 74,338.00 |
| Jun 30, 2021 | 62,449.00 |